Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Cohort Study for Severe Ischaemic Stroke

NCT03222024

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +21 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

NCT02113800

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum Berlin, Germany

View Trial Details

Completed

Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

NCT00859586

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

NCT01441063

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Castleman Disease, +29 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)

NCT00422799

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

NCT02410252

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +15 more
Locations: Amanda Centi Boston, Massachusetts, United States

View Trial Details

Completed

Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT02477215

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma

NCT00389051

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Kanagawa, Japan

Kyoto, Japan

Nagoya, Japan

Tokyo, Japan

View Trial Details

Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States

University of Minnesota Minneapolis, Minnesota, United States

Steven and Alexandra Cohen Children's Medical Center New York, United States

View all 15 locations

View Trial Details

Completed

Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma

NCT04061850

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea Seoul, South Korea

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions